News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Marvel Biosciences’ Lead Drug Candidate MB-204 Demonstrates a 400% Increase in the Survival Rate of Animals Treated with a High Dose of the Cancer Treatment Cis-Platinum
November 22, 2022
·
6 min read
Biotech Beach
Skye Bioscience to Present at RHK 2022 Disruptive Growth Conference
November 22, 2022
·
2 min read
Business
Advanced Proteome Therapeutics Announces Appointment of Mr. Cory Brandolini to the Board of Directors
November 22, 2022
·
4 min read
Scryb Congratulates Cybeats Technologies Corp. On Its Listing and Commencement of Trading on The CSE Under Ticker “CYBT”
November 21, 2022
·
3 min read
PreveCeutical Files Application for D-amino Acid Peptides
November 21, 2022
·
5 min read
Kiora Pharmaceuticals Enters Into Agreements to Raise $3.12 Million From the Exercise of Previously Issued Class A Warrants
November 18, 2022
·
3 min read
Data from Cohort 1 of SPEARHEAD-1 Trial at CTOS Continue to Support BLA Submission for Afami-cel in Synovial Sarcoma - Response Rate and Durability Remain Consistent
November 18, 2022
·
6 min read
Business
Meet Jim Corbett - Chief Executive Officer, AVITA Medical, Inc.
November 18, 2022
·
3 min read
RxLightning Debuts Revolutionary MedAccess Ecosystem
November 17, 2022
·
1 min read
Defence Therapeutics Completes Fully-Subscribed Debenture Financing of $2,355,000
November 17, 2022
·
3 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us